KKR
-
Japan API and CDMO M&A: Carve-Outs of Pharma Plants and Entry by Foreign CDMOs and Funds
(USD figures are converted at USD/JPY = 150 for reference and rounded. Company fiscal years are shown as FY2026/3, meaning the fiscal year ended March 2026. Japanese government statistics on pharmaceutical production are for calendar years. Other currencies are shown as disclosed.) In Japan API and CDMO M&A, Towa Pharmaceutical agreed in July 2026 to…
-
Japan Semiconductor Equipment M&A: Carve-outs from Large Groups and Capital Choices Under the Foreign Exchange Act
(USD figures are converted at USD/JPY = 150 for reference and rounded. Company fiscal years are shown as FY2026/3, meaning the fiscal year ended March 2026. Japanese fiscal years for industry statistics run from April to March.) In the industry for semiconductor manufacturing equipment and its components and peripheral materials, sales of Japanese-made equipment exceeded…